The European Centre for Disease Prevention and Control (ECDC) and the Africa Centres for Disease Control and Prevention (Africa CDC) discuss deeper collaboration for global health security
The meeting was an opportunity for ECDC and Africa CDC to take stock of ongoing areas of cooperation and look ahead to future efforts to enhance African, European and global health security. Since 2021, both agencies partner on a project, funded by the European Commission, to contribute to health security in Africa and globally by strengthening emergency preparedness and response, surveillance, epidemic intelligence, and workforce capacity-building.
'Close cooperation between ECDC and Africa CDC is essential for global health security. I look forward to even deeper collaboration moving forward and to working together towards global health security preparedness and response to confront future health threats. This work has already begun though ECDC's contributions to Africa CDC led outbreak responses through our EU Health Task Force,' said Dr. Pamela Rendi-Wagner, Director of ECDC.
In recognition of the evolving health threat landscape, Africa CDC and ECDC will collaborate on One Health workforce development through a Team Europe Initiative. Adopting a One Health approach is essential to combatting the silent pandemic of antimicrobial resistance – a significant threat to health and the functioning of health services on both continents.
'Africa CDC values its strong collaboration with ECDC in advancing global health security. Through the Africa CDC–ECDC Partnership, we committed to strengthen Africa's emergency preparedness, disease surveillance, and public health workforce. This visit reaffirms our commitment to expanding joint training, epidemic intelligence, and technical exchanges to equip our Member States with the needed support to tackle emerging health threats. Under the Africa-EU Global Gateway Partnership on Health, we remain dedicated to sustainability, innovation, and co-creating solutions for a healthier Africa and beyond,' said H.E. Dr. Jean Kaseya, Director General, Africa CDC.
ECDC's strengthened mandate has enabled the Agency to expand its international cooperation. The establishment of the EU Health Task Force has meant ECDC experts deployed in Africa ten times in 2024 to support local outbreak responses to mpox, Marburg and cholera.
In addition to their shared commitment to global health security and future technical collaboration, discussions focussed on outbreaks on the African continent as well as the concrete actions they are both taking to rebuild public trust in health authorities following the COVID-19 pandemic.
ECDC collaborates with centres for disease control beyond the EU at both regional and national levels as part of its long-term strategy to enhance international cooperation and coordination in addressing cross-border health threats. ECDC collaborates with the African, Caribbean, and Gulf supranational CDCs and has previously signed memoranda of understanding or administrative agreements with national centres around the world.
Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sharjah 24
21 hours ago
- Sharjah 24
Climate change made European heatwave up to 4C hotter study
Study findings A rapid study conducted by over a dozen researchers from five European institutions concluded that the heatwaves likely resulted in far more heat-related deaths than would have occurred without global warming. The heatwave, which occurred between late June and early July, saw temperatures soaring well above 40°C (104°F) in several countries, breaking records and triggering health warnings. Historical comparisons To assess the impact of climate change, scientists compared the intensity of the heatwave to a world unaffected by fossil fuel emissions. They found that the heatwave "would have been 2-4°C cooler" in all but one of the 12 cities studied, which collectively house over 30 million people, including major capitals like Paris, London, and Madrid. Increased risks Researcher Ben Clarke from Imperial College London highlighted that the added heat brings certain populations into more dangerous conditions. While some may find the temperatures comfortable, many others face significant health risks. Estimated death toll For the first time, the study aimed to estimate the death toll from this heatwave. Based on established research methods, it concluded that approximately 2,300 deaths occurred between June 23 and July 2 across the 12 cities. Alarmingly, about 1,500 of these deaths—roughly two-thirds—would not have happened without climate change. Vulnerable populations Heatwaves pose particular dangers to the elderly, sick individuals, young children, outdoor workers, and anyone exposed to high temperatures for extended periods. Urban areas exacerbate these risks, as paved surfaces and buildings absorb heat, making cities significantly hotter. The silent killer During the heatwave, large parts of southern Europe experienced "tropical nights," where overnight temperatures remained too high for adequate recovery. Garyfallos Konstantinoudis from Imperial College London noted that even a 2-4°C increase in heatwave temperatures can significantly impact survival rates. Authorities warn that it could take weeks to finalize the death toll from this recent heatwave, though similar events in the past have claimed tens of thousands of lives in Europe.
Zawya
a day ago
- Zawya
South Sudan's longest cholera outbreak enters critical stage
The outbreak – which started in September 2024 and was confirmed a month later – comes amidst a protracted humanitarian crisis exacerbated by rising intercommunal violence, climate shocks such as flooding and catastrophic hunger. 'Now, more than ever, collective action is needed to reduce tensions, resolve political differences and make tangible progress in implementing peace,' said Anita Kiki Gbeho, UN Resident and Humanitarian Coordinator in South Sudan. Alarming escalation Since the cholera outbreak was declared in October 2024, UN agencies and partners have documented over 80,000 cholera cases and 1,400 deaths. This is in addition to regional outbreaks of mpox, hepatitis and measles among other communicable diseases. South Sudanese authorities, civil society and UN agencies held an inter-ministerial meeting on Monday to discuss what they called an 'alarming escalation' in the spread of the outbreak. 'This is not merely a public health crisis, but a multi-sectoral emergency exacerbated by flooding, displacement, and limited access to basic services,' the ministers wrote in a communiqué released. The group resolved to facilitate unimpeded humanitarian access to areas which already have outbreaks and to other areas at risk for outbreaks. The Government of South Sudan will coordinate these efforts. Partners will also work to preposition materials, improve water and sanitation infrastructure and coordinate proactive and reactive vaccination campaigns. Time is running out With the peak of the rainy season on the horizon, the next eight weeks are critical in containing and mitigating the outbreak before severe flooding begins. 'Time is of the essence to prevent a further escalation of the outbreak,' the officials wrote. Floods more than double the frequency of cholera outbreaks by imperiling access to clean water and impeding humanitarian access to affected areas. And with rising global temperatures making floods more severe, millions of South Sudanese who were not previously in regions of concern may now be at risk for cholera outbreaks. A preventable disease Cholera is an acute diarrhoeal infection caused by consuming contaminated water or food. Although highly communicable, it is preventable through proper hygiene, regular handwashing, safe food preparation and storage, improved sanitation infrastructure, and vaccination. Symptoms typically include watery diarrhoea. Most cases are mild to moderate and can be treated effectively with oral rehydration salts (ORS) mixed with clean, boiled water. However, in severe cases, cholera can be fatal—sometimes within hours—if not treated promptly. Infected individuals can also transmit the disease through their faeces for up to ten days, even if they show no symptoms. Need for additional funds In South Sudan, the already inadequate water and sanitation infrastructure and overstretched public health system has further deteriorated as a result of displacement and conflict. This has ripened the conditions for the spread of cholera. The UN and its partners are working quickly to preposition emergency supplies, especially in these previously low-risk areas, but they are hampered by funding shortfalls. Agencies estimate that they will need $1.69 billion – of which they have only received $368 million – to address the many intersecting humanitarian needs in the country. Nevertheless, the group of ministers insisted that this outbreak is and must remain a priority for all involved. 'Cholera response and flood preparedness must be treated as urgent national priorities,' they said in the communiqué. Distributed by APO Group on behalf of UN News.
Al Etihad
a day ago
- Al Etihad
First infant malaria treatment receives approval: Novartis
9 July 2025 00:21 ZURICH (AFP)The first malaria treatment for newborns and young infants has received approval from Swiss health regulators, with eight African countries poised to roll the drug out rapidly, pharmaceutical giant Novartis said is a major killer in Africa, with the continent accounting for 95 percent of the 597,000 deaths from the disease worldwide in 2023, according to the World Health those deaths, about 76 percent -- more than 432,000 -- were children under five, according to the infant version of Novartis's Coartem treatment, also known as Riamet, was developed in collaboration with the Medicines for Malaria Venture (MMV), a Geneva-based organisation specialising in research and development of medicines against the disease."Until now, there has been no approved malaria treatment for infants weighing less than 4.5 kilograms (nine pounds 15 ounces)," Novartis said in a approval from Switzerland's health authority is for a dose designed for babies weighing two to five of the countries hit hardest by malaria -- Burkina Faso, Ivory Coast, Kenya, Malawi, Mozambique, Nigeria, Tanzania and Uganda -- participated in the Swiss approval countries are now expected to approve the treatment quickly themselves, under a programme to facilitate access to medicines for low- and middle-income countries, Novartis Swiss pharmaceutical company said it would introduce the treatment "on a largely not-for-profit basis" to increase access in places where the mosquito-borne disease is endemic. An estimated 263 million people worldwide had malaria in 2023, according to the WHO.
